Bio Rad Laboratories Stock In The News

BIO Stock  USD 254.45  9.44  3.85%   
Our overall analysis of Bio Rad's news coverage and content from conventional and social sources shows investors' bearish mood towards Bio Rad Laboratories. The specific impact of Bio Rad news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Bio Rad's overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Bio Rad headlines in addition to utilizing other, more conventional financial analysis modules. Check out Bio Rad Backtesting and Bio Rad Hype Analysis.

Bio Rad Today Top News and Investor Outlook

Yahoo News
Bio-Rad Laboratories, Inc. (NYSE:BIO) is a favorite amongst institutional investors who own 60%
https://finance.yahoo.com/news/bio-rad-laboratories-inc-nyse-195812365.html
 Bullish
Yahoo News
Is Bio-Rad Laboratories, Inc. (BIO) the Best Medical Technology Stock to Buy According to Analysts?
https://finance.yahoo.com/news/bio-rad-laboratories-inc-bio-050029408.html
 Bullish
Yahoo News
Bio-Rad (BIO) International Revenue Performance Explored
https://finance.yahoo.com/news/bio-rad-bio-international-revenue-141508443.html
 Bullish
Yahoo News
HSIC Q4 Earnings Match Estimates, Margins Up, Stock Falls in Premarket
https://finance.yahoo.com/news/hsic-q4-earnings-match-estimates-162800199.html
 Bullish
Yahoo News
Veracyte Stock Falls Despite Q4 Earnings and Revenue Beat
https://finance.yahoo.com/news/veracyte-stock-falls-despite-q4-130000857.html
 Bullish
Yahoo News
Globus Medical Q4 Earnings & Revenues Top, Margins Expand, Stock Dips
https://finance.yahoo.com/news/globus-medical-q4-earnings-revenues-131700477.html
 Bullish
Yahoo News
EXAS Q4 Loss Narrower Than Expected, Stock Falls, Revenues Up Y/Y
https://finance.yahoo.com/news/exas-q4-loss-narrower-expected-130600074.html
 Neutral
Yahoo News
Penumbra Q4 Earnings & Revenues Top, Margins Expand, Stock Rises
https://finance.yahoo.com/news/penumbra-q4-earnings-revenues-top-121400806.html
 Bullish
Investors Business Daily at Macroaxis
India's market regulator proposes steps to secure investors' trading accounts
https://www.reuters.com/world/india/indias-market-regulator-proposes-steps-secure-investors-trading-accounts-2025-02-18/
 Bullish
Yahoo News
Medtronic Q3 Earnings Top Estimates, Revenues Miss, Stock Tumbles
https://finance.yahoo.com/news/medtronic-q3-earnings-top-estimates-141800403.html
 Bullish

Bio Rad Laboratories Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Bio and other traded companies coverage with news coverage. We help investors stay connected with Bio headlines for the 14th of March 2025 to make an informed investment decision based on correlating the impacts of news items on Bio Stock performance. Please note that trading solely based on the Bio Rad Laboratories hype is not for everyone as timely availability and quick action are needed to avoid losses.
Bio Rad's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Bio Rad Laboratories investors visualize upcoming and past events in order to time the market based on Bio Rad Laboratories noise-free hype analysis.
Bio Rad stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Bio earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Bio Rad that are available to investors today. That information is available publicly through Bio media outlets and privately through word of mouth or via Bio internal channels. However, regardless of the origin, that massive amount of Bio data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Bio Rad news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Bio Rad relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Bio Rad's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Bio Rad alpha.

Bio Largest EPS Surprises

Earnings surprises can significantly impact Bio Rad's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
1993-02-12
1992-12-310.070.06-0.0114 
1994-02-09
1993-12-310.090.130.0444 
1993-04-28
1993-03-310.10.140.0440 
1996-05-01
1996-03-310.340.390.0514 
1995-08-02
1995-06-300.220.270.0522 
1998-12-01
1998-09-300.140.08-0.0642 
View All Earnings Estimates

Bio Rad Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Bio Rad Laboratories Stock. Current markets are strongly bullish. About 93% of major world exchanges and indexes are currently up. See today's market update for more information.
Macroaxis News: globenewswire.com
11th of March 2025
Neurological Biomarkers Global Market Review 2020-2024 and Forecast to 2030, Featuring Ana...
at globenewswire.com 
Google News at Macroaxis
10th of March 2025
Bio-Rad stock touches 52-week low at 248.05 amid market shifts - Investing.com India
at news.google.com 
Yahoo News
6th of March 2025
Microplates Market to Reach USD 1,301.08 million by 2032, Growing at an 4.50 percent CAGR ...
at finance.yahoo.com 
Yahoo News
4th of March 2025
OncoCyte Corporation Among Penny Stocks with Insider Buying in 2025
at finance.yahoo.com 
Macroaxis News: globenewswire.com
3rd of March 2025
High-Throughput Screening Technology Analysis and Global Markets 2021-2024 2025-2029 with ...
at globenewswire.com 
news
27th of February 2025
Principal Financial Group Inc. Divests 234 Shares of Bio-Rad Laboratories, Inc.
at kalkinemedia.com 
zacks News
26th of February 2025
Bio-Rad International Revenue Performance Explored
at zacks.com 
Yahoo News
25th of February 2025
Capillary Electrophoresis Market Report 2025-2030, with Profiles of Bio-Rad Laboratories, ...
at finance.yahoo.com 
Yahoo News
21st of February 2025
Bio Detectors and Accessories Market to Reach USD 52.9 Billion by 2032 SNS Insider
at finance.yahoo.com 
prnewswire News
14th of February 2025
Dignify Therapeutics Highlights Clinical Development Plans at BIO CEO Investor Conference
at prnewswire.com 
zacks News
4th of February 2025
Has BioRad Laboratories Outpaced Other Medical Stocks This Year
at zacks.com 
Yahoo News
17th of January 2025
Is Adaptive Biotechnologies Stock Outpacing Its Medical Peers This Year
at finance.yahoo.com 

Bio Rad Investors Sentiment

The influence of Bio Rad's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Bio. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Bio Rad's public news can be used to forecast risks associated with an investment in Bio. The trend in average sentiment can be used to explain how an investor holding Bio can time the market purely based on public headlines and social activities around Bio Rad Laboratories. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Bio Rad's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Bio Rad's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Bio Rad's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Bio Rad.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Bio Rad in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Bio Rad's short interest history, or implied volatility extrapolated from Bio Rad options trading.
When determining whether Bio Rad Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bio Rad's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Rad Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Rad Laboratories Stock:
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bio Rad. If investors know Bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bio Rad listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
5.412
Earnings Share
(65.35)
Revenue Per Share
90.965
Quarterly Revenue Growth
(0.02)
Return On Assets
0.0155
The market value of Bio Rad Laboratories is measured differently than its book value, which is the value of Bio that is recorded on the company's balance sheet. Investors also form their own opinion of Bio Rad's value that differs from its market value or its book value, called intrinsic value, which is Bio Rad's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bio Rad's market value can be influenced by many factors that don't directly affect Bio Rad's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bio Rad's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio Rad is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio Rad's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.